000			02055nam a22002537a 4500
003			OSt
005			20240305193745.0
008			221206b |||||||| |||| 00| 0 eng d
028			_b Phone: +255 28 298 3384
028			_b Fax: +255 28 298 3386
028			_b Email: vc@bugando.ac.tz
028			_bWebsite: www.bugando.ac.tz
040			_bEnglish _cDLC
041			_aEnglish
100			_aRobert N Peck _922982
245			_aCutaneous anthrax in the Artibonite Valley of Haiti: 1992–2002
260			_aMwanza, Tanzania: _bAmerican Society of Tropical Medicine and Hygiene & _bCatholic University of Health and Allied Sciences [CUHAS – Bugando] _c2007/11/1
300			_aPages 806-811
490			_vThe American journal of tropical medicine and hygiene Volume 77 Issue 5
520			_aAbastract: More cutaneous anthrax cases were noted at Hospital Albert Schweitzer (HAS) in the Artibonite Valley of Haiti. We examine the incidence of anthrax in the Artibonite between 1992 and 2002, describe the clinical presentation of cutaneous anthrax, and determine risk factors for anthrax. In 1992 HAS reported 1 case of anthrax for an incidence of 4 cases per million persons/year. In 2002, there were 20 cases of anthrax for an incidence of 72 cases per million persons/year. This is a 17-fold increase (P 0.0002). Causes of death from anthrax included asphyxiation from edema of the neck with tracheal compression and concurrent gastrointestinal anthrax. Butchering cattle that had died of illness was identified as a risk factor. The incidence of human anthrax has increased in the Artibonite Valley and is a cause of significant mortality. Control of anthrax in humans depends on improved animal vaccination programs.
700			_aDaniel W Fitzgerald _923036
856			_uhttps://www.researchgate.net/profile/Robert-Peck-6/publication/5863024_Cutaneous_Anthrax_in_the_Artibonite_Valley_of_Haiti_1992-2002/links/5f7317c2458515b7cf567272/Cutaneous-Anthrax-in-the-Artibonite-Valley-of-Haiti-1992-2002.pdf
942			_2ddc _cVM
999			_c19925 _d19925